Navigation Links
Laquinimod in Medical News

Experimental Drug Fights Multiple Sclerosis Activity

...ltiple sclerosis," Richert explained. "That is how laquinimod was born." laquinimod works by binding to receptors on immune cells, iso...ned to receive either a placebo, 0.3 milligrams of laquinimod or 0.6 milligrams of...
Laquinimod in Medical Technology

Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

...IIb study demonstrated that an oral 0.6 mg dose of laquinimod given daily significantly reduced magnetic resonan...atment of the disease, but an oral therapy such as laquinimod would represent a milestone for patients as it wou...s have already demonstrated the positive effect of laquinimod versus placebo, but these new data confirmed that ...
Laquinimod in other areas

Laquinimod - Wikipedia, the free encyclopedia

Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva. It is currently investigated as an oral treatment of multiple sclerosis (MS).

Multiple Sclerosis Resource Centre Laquinimod

Laquinimod page with information on Laquinimod and Multiple Sclerosis Research in the MS Research News section of the MSRC website.

Multiple Sclerosis Drug Clears Hurdle on RxList

Learn more about the new drug laquinimod that might treat multiple sclerosis (MS), which can cause tingling, fatigue and loss of vision.

Laquinimod reduces multiple sclerosis disease activity | Reuters ...

NEW YORK (Reuters Health) - In patients with relapsing-remitting multiple sclerosis, treatment with laquinimod, a new immunomodulatory agent, can significantly ...

This Is MS - Laquinimod (oral therapy) Successful in Phase II Trial ...

An independent community for those affected by Multiple Sclerosis featuring the latest news and research ... Results show that laquinimod reduced those lesions ...

Treatment with laquinimod reduces development of active MRI lesions in ...

Background: Laquinimod is a novel immunomodulatory substance developed as an ... There was a significant difference between laquinimod 0.3 mg and placebo for the ...
Other Tags
(Date:11/22/2014)... classic black prom dress will never go out of fashion. ... its new items of black prom gowns . Now ... discount, up to 70% off. People throughout the world can ... dresses, made with the best materials, can make wearers feel ... the company provides these beautiful outfits in a huge range ...
(Date:11/22/2014)... York, NY (PRWEB) November 22, 2014 ... Therapeutics Goods Administration (TGA) approved it for use ... was approved and listed within the Therapeutic Goods ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione will ... a biotech specialist that sources and imports fine ...
(Date:11/22/2014)... 22, 2014 Nocturia is defined ... complaint that the individual has to wake at ... report “Nocturia – Pipeline Review, H2 2014” provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ...
(Date:11/22/2014)... 22, 2014 (HealthDay News) -- The wide variety and ... a threat for people with food allergies, an expert ... so many types of food allergies that it can ... holidays," Dr. Guha Krishnaswamy, director of allergy and clinical ... a hospital news release. "If you know you ...
(Date:11/22/2014)... Hastings and Hastings, a discount accident ... providing clients with the option of leaving an online ... flexible, intuitive and easy to navigate website that has ... Google + allows clients to research the Hastings and ... informed decision when retaining an attorney. Those who have ...
Breaking Medicine News(10 mins):Health News:New Black Prom Dresses from BellasDress.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:'Tis the Season of Challenges for Those With Food Allergies 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 2Health News:Hastings and Hastings Announces Providing Clients with the Option of Leaving an Online Review Using Google + 3
(Date:11/3/2014)... DUBLIN , Nov. 3, 2014 Research ... report "Cell Therapy - Technologies, Markets and Companies" ... evaluates cell therapy technologies and methods, which have already started ... Hematopoietic stem cell transplantation is replacing the old fashioned bone ... described. Cell therapy is bound to become a part of ...
(Date:11/3/2014)... weight and preterm birth are linked to increased risk ... in the American College of Rheumatology (ACR) journal, ... weight and pre-term babies were not at greater risk ... , According to the ACR, 27 million Americans over ... Symptoms of OA range from mild to severe and ...
(Date:11/2/2014)... fascinating to put a flashlight up to our palms ... University in St. Louis engineers are using a similar ... improve imaging of cancerous tissues and to develop potential ... Beare Distinguished Professor of Biomedical Engineering at the School ... time-reversal technology that allows researchers to better focus light ...
Breaking Biology News(10 mins):Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3Preterm, low birth-weight babies may need new hips in adulthood 2Improving imaging of cancerous tissues by reversing time 2
Other Contents